Use of Daratumumab in Relapsed Refractory Multiple Myeloma and Clinical Experience

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Kübra Oral
DOI: 10.5281/zenodo.18663726
Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Monoclonal and Polyclonal Antibodies Research Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
16 February 2026
Language
EN